重症监护与外科中的血小板输注:当代实践的循证综述与未来方向
该综述聚焦重症监护、外科和创伤患者中血小板减少的普遍性及血小板输注实践。作者通过PubMed和Cochrane Central Register of Controlled Trials检索并选取153篇评估外科与重症人群中血小板输注证据的文献,探讨血小板输注阈值、创伤中血小板输注的作用、抗凝逆转管理以及床旁实验室检测。文章还讨论了输血医学进展及可工程化的合成血小板替代物在未来潜在应用。综述强调需理解现行照护标准并识别可能存在的不足,以推动血小板输注指南的制定。
要点
- 血小板减少在重症监护、外科和创伤环境中普遍存在,相当比例患者住院期间接受血小板输注。
- 血小板输注实践差异大,亟需理解现行照护标准并识别其中可能存在的不足。
- 综述通过PubMed和Cochrane Central Register of Controlled Trials检索并选取153篇文献评估外科与重症人群中血小板输注的证据。
- 综述重点关注创伤中血小板输注的作用、抗凝管理及逆转、以及床旁实验室检测。
- 作者还讨论了输血医学进展及可工程化的合成血小板替代物的未来潜在应用。
适用人群与场景
- 重症监护、外科和创伤环境中出现血小板减少的患者。
研究设计与关键结果
- 综述通过PubMed和Cochrane Central Register of Controlled Trials检索并选取153篇评估外科与重症监护人群中支持血小板输注的当前数据的文献。
- 综述探讨了多种重症监护和外科环境下的血小板输注阈值与实践的证据和推荐,并特别关注创伤中血小板输注的作用、抗凝管理及逆转、以及床旁实验室检测。
- 综述还讨论了输血医学进展以及可工程化的合成血小板替代物用于未来潜在应用。
证据类型、等级与局限
- 证据类型:文献综述;检索PubMed和Cochrane Central Register of Controlled Trials,选取153篇文献。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Thrombocytopenia is prevalent in critical care, surgical, and trauma settings. Despite the fact that a significant proportion of these patients receive platelet transfusion during their hospital course, much work remains to be done with regard to development of platelet transfusion guidelines. Given the wide variety of platelet transfusion practices and the frequency with which patients present with thrombocytopenia, it is paramount to understand standards of care and to identify deficiencies that may exist. This review explores evidence and recommendations for platelet transfusion thresholds and practices in a variety of critical care and surgical settings with specific focus on the role of platelet transfusion in trauma, management and reversal of anticoagulation, and point of care laboratory assays. To this end, a literature review was performed utilizing PubMed and Cochrane Central Register of Controlled Trials to select 153 manuscripts that evaluate the current data supporting platelet transfusions in surgical and critical care populations. Advances in transfusion medicine and synthetic platelet substitutes that can be engineered for potential future applications will also be discussed.
参考来源
- Etchill EW, Myers SP, Raval JS, et al. Platelet Transfusion in Critical Care and Surgery: Evidence-Based Review of Contemporary Practice and Future Directions. Shock. 2017. PMID: 27849676. doi:10.1097/SHK.0000000000000794
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。